Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease.
about
The role of free radicals in the aging brain and Parkinson's Disease: convergence and parallelismMechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative diseaseNRF2-regulation in brain health and disease: implication of cerebral inflammationGenetic Variations and mRNA Expression of NRF2 in Parkinson's Disease.NRF2 activation restores disease related metabolic deficiencies in olfactory neurosphere-derived cells from patients with sporadic Parkinson's diseaseHydrogen peroxide responsive miR153 targets Nrf2/ARE cytoprotection in paraquat induced dopaminergic neurotoxicity.SKN-1/Nrf2 inhibits dopamine neuron degeneration in a Caenorhabditis elegans model of methylmercury toxicity.The endotoxin-induced neuroinflammation model of Parkinson's disease.Association of Nrf2 polymorphism haplotypes with acute lung injury phenotypes in inbred strains of mice.Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson's disease - a multicenter study.Genetic activation of Nrf2 signaling is sufficient to ameliorate neurodegenerative phenotypes in a Drosophila model of Parkinson's disease.Comprehensive assessment of genetic sequence variants in the antioxidant 'master regulator' NRF2 in idiopathic Parkinson's disease.Relationship between air pollution, NFE2L2 gene polymorphisms and childhood asthma in a Hungarian population.RBM45 Modulates the Antioxidant Response in Amyotrophic Lateral Sclerosis through Interactions with KEAP1.Thiol-redox signaling, dopaminergic cell death, and Parkinson's diseaseNrf2--a therapeutic target for the treatment of neurodegenerative diseases.Genetic Polymorphisms of Transcription Factor NRF2 and of its Host Gene Sulfiredoxin (SRXN1) are Associated with Cerebrovascular Disease in a Finnish Cohort, the TAMRISK StudyNFE2L2 variations reduce antioxidant response in patients with Parkinson disease.Genomic structure and variation of nuclear factor (erythroid-derived 2)-like 2Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's DiseaseLack of association between nuclear factor erythroid-derived 2-like 2 promoter gene polymorphisms and oxidative stress biomarkers in amyotrophic lateral sclerosis patients.Brain rust: recent discoveries on the role of oxidative stress in neurodegenerative diseases.P62/SQSTM1 at the interface of aging, autophagy, and disease.Antioxidative defense mechanisms controlled by Nrf2: state-of-the-art and clinical perspectives in neurodegenerative diseases.Nrf2: a modulator of Parkinson's disease?Pinocembrin attenuates 6-OHDA-induced neuronal cell death through Nrf2/ARE pathway in SH-SY5Y cells.Sustained Effects of Neonatal Systemic Lipopolysaccharide on IL-1β and Nrf2 in Adult Rat Substantia Nigra Are Partly Normalized by a Spirulina-Enriched Diet.Promoter region variation in NFE2L2 influences susceptibility to ototoxicity in patients exposed to high cumulative doses of cisplatin.Polydatin inhibits mast cell-mediated allergic inflammation by targeting PI3K/Akt, MAPK, NF-κB and Nrf2/HO-1 pathways.Nrf2 mitigates LRRK2- and α-synuclein-induced neurodegeneration by modulating proteostasis.The Nrf2/ARE Pathway: A Promising Target to Counteract Mitochondrial Dysfunction in Parkinson's Disease.Targeting Nrf2-mediated gene transcription by extremely potent synthetic triterpenoids attenuate dopaminergic neurotoxicity in the MPTP mouse model of Parkinson's disease.Association of NFE2L2 and KEAP1 haplotypes with amyotrophic lateral sclerosis.Hydralazine induces stress resistance and extends C. elegans lifespan by activating the NRF2/SKN-1 signalling pathway.Nrf2-ARE signals mediated the anti-oxidative action of electroacupuncture in an MPTP mouse model of Parkinson's disease.α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease.A Novel Compound ITC-3 Activates the Nrf2 Signaling and Provides Neuroprotection in Parkinson's Disease Models.Deficiency in the transcription factor NRF2 worsens inflammatory parameters in a mouse model with combined tauopathy and amyloidopathy.
P2860
Q26852148-E657CCE4-DCEB-42D3-879A-FBCDCD50ECC9Q28394732-34D10BF5-C06F-49EC-98CF-472598BECBF1Q28397785-36BFF373-1EE2-4FD5-A8CE-DB39BE8DB37BQ33692840-2C0F61BF-F572-40D7-9B6B-C07350E03C1BQ33958143-31FDD224-B6FA-4960-A7F3-AC593AED16DCQ34004577-1A203633-F3D9-469D-B572-2ECEC4491232Q34413384-B6E6C1FA-9596-4A1E-A36D-DCD854BBD166Q34557246-A276571D-1C35-4888-805D-C3FC9A4272DEQ34981744-5442F781-BEB1-4DCC-BEF0-82A0DC1F8598Q35104608-8F6320D5-D323-4998-9944-EF20EAC0BE12Q35232644-C1F26D97-AF25-4747-944C-9E1CCD4BEBE6Q35641233-D2A30913-1FD9-401E-9622-2D353B4FEEFCQ35700052-5D9B48CE-BA5C-44E6-AFB0-8B98B5642694Q35764195-4B839012-0915-4EE5-B8BC-FBFECCCF9E33Q36326535-79599D23-B11E-4AA3-9EE8-5C2AF2C71811Q36732766-B52ABD26-55CD-4981-9C35-CF0B258B0BD0Q36934471-3E187FAC-BF6A-4143-B340-90657B38196DQ36998083-D3934EEF-38AA-4A60-9AF2-A554A25A1B2EQ37044968-194AFE38-2318-48C0-9846-8D2B20E95D1EQ37091371-C1DB8946-7FFF-461D-9934-8B0379B50FA0Q37615036-D17457BD-C4FE-4595-857B-ABBBEEE48F17Q38009974-A7A5697E-6FF1-459E-958B-7B22E70FCA8BQ38190037-E6341C38-E85E-4A78-B68E-BA531629DAB1Q38244092-9F494A4C-3EFC-418F-936F-FFD14FECCFE9Q38825568-AE516809-9731-4EB5-9E63-94D03EE4C975Q38942155-0E71EA60-85B1-4277-90C7-EB0DFEBBC342Q40418219-DA1BCBCD-F64E-49BA-9E7C-2B6A76327EF8Q40600080-3E057A38-E311-4414-B786-AD5AA56E94A1Q41717527-8BC3110D-15A8-4902-B390-8B0C1E332740Q41827284-4DAED1CE-F492-49FE-BE01-91F1ACF4C020Q42010967-3CD5A0A3-66B6-4071-8D3C-3F89ADE270CDQ42116615-7035538E-DFE8-45FF-9DBF-D8DB08FD84B4Q46022971-3458CB7A-3F16-41D5-AE4F-2BE10E96DA15Q47106243-AACC4A5A-5FD5-4D09-AF40-79EFD3EA3322Q47683444-3BFB705A-991E-4472-A6D3-098CF111ECB1Q48561683-F29934BC-9104-4FCC-8318-1C301C93596FQ53203837-290B1EB2-F68F-415B-BACE-C624D53D3D80Q55715569-1BBE9DFF-3050-4B27-A167-DE764FA2880C
P2860
Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease.
@ast
Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease.
@en
Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease.
@nl
type
label
Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease.
@ast
Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease.
@en
Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease.
@nl
prefLabel
Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease.
@ast
Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease.
@en
Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease.
@nl
P2093
P2860
P50
P356
P1433
P1476
Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease.
@en
P2093
Anna Håkansson
Dragana Celojevic
Hans Nissbrandt
Malin von Otter
Mateusz Kurzawski
Monika Bialecka
Ola Hammarsten
Petra Bergström
Sara Landgren
P2860
P2888
P356
10.1186/1471-2350-11-36
P577
2010-03-02T00:00:00Z
P5875
P6179
1036758606